Peter Kolchinsky latest buys and sells

53 buys and sells in Peter Kolchinsky's latest 13F filing, largest first. The largest is the new position in PBLS, $791.9M or 6.9% of the reported portfolio.

Moves
53
Combined size
$3B

Key facts

Moves
53
New positions
16
Complete sales
17
Largest move
PBLS, $791.9M
Latest filing
Aug 14, 2026
Peter Kolchinsky ✕

From RA Capital Management's filing for (Q2 2026), filed , against the filing for Mar 31, 2026.

Peter Kolchinsky: buys and sells, latest filings
#StockMoveSharesSizeOf portfolio
1Parabilis Medicines IncPBLS▲ New+28.93M$791.9M6.88%
2Hemab Therapeutics HoldingsCOAG▲ New+7.81M$286.8M2.49%
3Dianthus Therapeutics IncDNTH▼ Sold out—$219.2M1.90%
4
Nuvalent Incno ticker on file
▼ Reduced 51%−1.29M$159M1.38%
5Abivax SAABVX▲ New+1.13M$150.9M1.31%
6Oruka Therapeutics IncORKA▲ New+1.55M$148M1.29%
7Praxis Precision MedicinesPRAX▼ Sold out—$120.4M1.05%
8Sarepta Therapeutics IncSRPT▼ Sold out—$84.9M0.74%
9Edgewise Therapeutics IncEWTX▼ Reduced 20%−2.04M$82.7M0.72%
10Spyre Therapeutics IncSYRE▼ Sold out—$81.8M0.71%
11Artiva Biotherapeutics IncARTV▲ Added 82%+8.1M$78.6M0.68%
12Intellia Therapeutics IncNTLA▲ New+4.53M$76.6M0.67%
13Definium Therapeutics IncDFTX▲ New+1.5M$70.6M0.61%
14Sana Biotechnology IncSANA▲ New+18.75M$65.4M0.57%
15Vor Biopharma IncVOR▼ Reduced 56%−3M$55.3M0.48%
16Fulcrum Therapeutics IncFULC▼ Sold out—$46.4M0.40%
17Olema Pharmaceuticals IncOLMA▼ Sold out—$38.8M0.34%
18Prelude Therapeutics IncPRLD▲ New+6.48M$34.5M0.30%
19Design Therapeutics IncDSGN▼ Sold out—$31.6M0.27%
20Aclaris Therapeutics IncACRS▲ Added 87%+5.92M$31.3M0.27%
21Q32 Bio IncQTTB▲ New+2.33M$29.7M0.26%
22Editas Medicine IncEDIT▲ New+8.89M$28.8M0.25%
23Solid Biosciences IncSLDB▲ Added 29%+2.7M$26.9M0.23%
24Geron CorpGERN▼ Reduced 33%−20.96M$26.8M0.23%
25Travere Therapeutics IncTVTX▼ Sold out—$22.2M0.19%
26Grail IncGRAL▼ Sold out—$22.1M0.19%
27Relmada Therapeutics IncRLMD▼ Sold out—$20.5M0.18%
28Altimmune IncALT▲ New+6.5M$19.8M0.17%
29Faeth Therapeutics IncFTH▲ New+722.02K$18.1M0.16%
30Sutro Biopharma IncSTRO▼ Sold out—$17.8M0.15%
31Aura Biosciences IncAURA▲ New+2.5M$17.8M0.15%
32Contineum Therapeutics IncCTNM▼ Sold out—$16.9M0.15%
33Inspire Med Systems IncINSP▼ Sold out—$16.8M0.15%
34Seaport Therapeutics IncSPTX▲ New+700K$15.2M0.13%
35Hinge Health IncHNGE▼ Sold out—$14.1M0.12%
36GeneDx Holdings CorpWGS▼ Sold out—$13.5M0.12%
37Atrium Therapeutics IncRNA▼ Sold out—$11.6M0.10%
38Acrivon Therapeutics IncACRV▲ Added 47%+3.89M$6.9M0.06%
39Avalo Therapeutics IncAVTX▲ Added 51%+337.05K$6.2M0.05%
40Aktis Oncology IncAKTS▼ Reduced 13%−188.63K$6.1M0.05%
41Xencor IncXNCR▲ Added 7.7%+377.08K$6.1M0.05%
42Jatt II Acquisition CorpJATT▲ New+500K$5.7M0.05%
43Maplight Therapeutics IncMPLT▼ Sold out—$5M0.04%
44Amanat Acquisition CorpAMAN▲ New+375K$3.8M0.03%
45Adicet Bio IncACET▼ Reduced 21%−250.01K$2.2M0.02%
46Werewolf Therapeutics IncHOWL▼ Reduced 64%−4.29M$1.5M0.01%
47Rezolute IncRZLT▲ Added 2.9%+265.3K$1.4M0.01%
48GH Research PLCGHRS▼ Reduced 0.5%−39.92K$1.1M0.01%
49Zai Lab LtdZLAB▲ Added 0.6%+36.53K$694K0.01%
50Ovid Therapeutics IncOVID▼ Reduced 2.0%−213.21K$573.5K0.00%
51Bioage Labs IncBIOA▲ Added 1.3%+20.96K$513.8K0.00%
52Palatin Technologies IncPTN▼ Reduced 11%−7.88K$85K0.00%
53Damora Therapeutics IncDMRA▲ Added 0.02%+480$12.5K0.00%

Questions and answers

What did Peter Kolchinsky buy last quarter?

The largest purchases in the latest 13F filing: PBLS, $791.9M; COAG, $286.8M; ABVX, $150.9M; ORKA, $148M; ARTV, $78.6M; NTLA, $76.6M.

What did Peter Kolchinsky sell last quarter?

The largest sales in the latest 13F filing: DNTH, $219.2M; Nuvalent Inc, $159M; PRAX, $120.4M; SRPT, $84.9M; EWTX, $82.7M; SYRE, $81.8M.

How is the size of a buy or sell worked out?

As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.

Learn

Cite this page

Funkfolio, “Peter Kolchinsky: buys and sells, Q2 2026 13F”, data as of 14 August 2026. https://funkfolio.com/gurus/activity?investor=peter-kolchinsky

Underlying data: SEC EDGAR, Form 13F-HR.

Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.